A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch for Clinical Islet Transplantation
Phase of Trial: Phase I/II
Latest Information Update: 20 Dec 2018
At a glance
- Drugs Islet cell replacement therapy (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- Sponsors Sernova Corp
- 20 Dec 2018 According to a Sernova media release, company is expecting to report preliminary safety data in the first half of 2019 and preliminary efficacy data in the second half of 2019.
- 20 Dec 2018 According to a Sernova media release, company expects completion of enrollment of the first patient cohort to be January 2019 and full enrollment to be completed by mid- 2019.
- 20 Dec 2018 According to a Sernova media release, first patient has been enrolled.